Skip to main content

Table 1 Laboratory findings in March 2007

From: Persistent Graves’ hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report

Hematology

 Red blood cells

489×104/μL

(427–571)

 Hemoglobin

14.2 g/dL

(12.4–17.2)

 Hematocrit

42.1%

(38.7–50.3)

 White blood cells

5300/μL

(4000–9000)

 Platelets

14.8×104/μL

(12.0–30.0)

Chemistry

 Total protein

6.7 g/dL

(6.7–8.3)

 Albumin

3.9 g/dL

(3.8–5.3)

 Aspartate aminotransferase

24 IU/L

(13–33)

 Alanine aminotransferase

29 IU/L

(8–42)

 Urea nitrogen

13.8 mg/dL

(8.0–22.0)

 Creatinine

0.44 mg/dL

(0.40–0.70)

 Sodium

143 mmol/L

(137–147)

 Potassium

4.3 mmol/L

(3.5–4.7)

 Chloride

107 mmol/L

(98–108)

 C-reactive protein

0.08 mg/dL

(<0.30)

 Casual plasma glucose

6.1 mmol/L

(3.9–7.8)

 Total cholesterol

135 mg/dL

(130–220)

 Triglycerides

76 mg/dL

(50–130)

 Thyroid-stimulating hormone

<0.01 μU/mL

(0.30–4.30)

 Free triiodothyronine

>25.0 pg/mL

(1.71–3.71)

 Free thyroxine

7.90 ng/dL

(0.70–1.48)

 Second-generation TBII

2.1 IU/L

(<1.0)

 Thyroid-stimulating antibody

156%

(0–180)

 Thyroid peroxidase antibody

84.3 U/mL

(<0.3)

 Thyroglobulin antibody

185 U/mL

(<0.3)

 Anti-nuclear antibody

<40 titer

(<40)

  1. The reference range for each parameter is shown in parentheses. TBII thyroid-stimulating hormone-binding inhibitory immunoglobulin